ABG Innovation Capital Partners III’s Atea Pharmaceuticals AVIR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,265,631	Closed	-$27.2M	–	7
2021 Q2	$27.2M	Buy	+1,265,631	New	+$27.2M	91.01%	1
2021 Q1	–	Sell	-2,639,178	Closed	-$110M	–	8
2020 Q4	$110M	Buy	+2,639,178	New	+$110M	64.92%	1